AAAAAA

   
Results: 1-3 |
Results: 3
Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity
Authors: Robin-Jagerschmidt, C Wurtz, JM Guillot, B Gofflo, D Benhamou, B Vergezac, A Ossart, C Moras, D Philibert, D
Citation: C. Robin-jagerschmidt et al., Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity, MOL ENDOCR, 14(7), 2000, pp. 1028-1037
The pharmacological profile of a novel norpregnane progestin (trimegestone)
Authors: Philibert, D Bouchoux, F Degryse, M Lecaque, D Petit, F Gaillard, M
Citation: D. Philibert et al., The pharmacological profile of a novel norpregnane progestin (trimegestone), GYNECOL END, 13(5), 1999, pp. 316-326
Synthesis and relative binding affinity to steroid receptors and antiproliferative activity on MCF-7 cells of 2,3-disubstituted indenes
Authors: Kirkiacharian, S Koutsourakis, PG Philibert, D Bouchoux, F Van de Velde, P
Citation: S. Kirkiacharian et al., Synthesis and relative binding affinity to steroid receptors and antiproliferative activity on MCF-7 cells of 2,3-disubstituted indenes, FARMACO, 54(10), 1999, pp. 678-683
Risultati: 1-3 |